Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction.
Divaka PereraTim ClaytonPeter D O'KaneJohn Pierre GreenwoodRoshan WeerackodyMatthew RyanHolly P MorganMatthew DoddRichard EvansRuth CanterSophie ArnoldLana J DixonRichard J EdwardsKalpa De SilvaJames C SprattDwayne ConwayJames CottonMargaret McEntegartAmedeo ChiribiriPedro SaramagoAnthony GershlickAjay M ShahAndrew L ClarkMark C Petrienull nullPublished in: The New England journal of medicine (2022)
Among patients with severe ischemic left ventricular systolic dysfunction who received optimal medical therapy, revascularization by PCI did not result in a lower incidence of death from any cause or hospitalization for heart failure. (Funded by the National Institute for Health and Care Research Health Technology Assessment Program; REVIVED-BCIS2 ClinicalTrials.gov number, NCT01920048.).
Keyphrases
- left ventricular
- heart failure
- healthcare
- quality improvement
- acute myocardial infarction
- percutaneous coronary intervention
- cardiac resynchronization therapy
- public health
- hypertrophic cardiomyopathy
- coronary artery bypass grafting
- mental health
- aortic stenosis
- mitral valve
- left atrial
- oxidative stress
- palliative care
- acute coronary syndrome
- health information
- coronary artery disease
- blood pressure
- atrial fibrillation
- risk factors
- st segment elevation myocardial infarction
- antiplatelet therapy
- minimally invasive
- cerebral ischemia
- human health
- stem cells
- blood brain barrier
- bone marrow
- health promotion
- radiofrequency ablation
- subarachnoid hemorrhage
- chronic pain
- acute heart failure
- aortic valve